Phase
Startup
Cirkulär
Cirkulär is developing the next generation of biological factories – powered by fungal cells. The versatile technology platform enables the company to help serve various purposes and industries that embrace sustainable transformation.
Eric Öste, CEO, has a Master’s degree in business from Stockholm School of Economics and a Master’s degree in Biotechnology from Columbia University. Together with Sebastian Carreno Correa, Bsc. Engineering, he founded the company in 2019.
New technologies for next-gen antibody therapeutics
Single Molecule Nanowire Biosensors for Diagnostics
Medicines for acute systemic inflammatory diseases
Cancer immunotherapies based in cell reprogramming
Introducing the fungal based industrial revolution
Automated microscopy image acquisition and analysis
Rapid analyses of human genetic variants
Nanosystems for oral biologics delivery
Fighting iron deficiency
Implants of magnesium alloys
Developing future targeted immunotherapies in cancer
Digital service for patients
Ultrasound analysis for stroke risk assessment
Medical device that reduces pain during vein operation
Cloud-based solutions for genomics data
A reusable, user-friendly, and sustainable pregnancy test
Develops the first effective treatment for hypothyroidism
Builds gene therapy viral vectors
Early detection of pancreatic cancer
Bio-based vegan coating for fruits and vegetables
Equipment that improves the function of cultivated cells
Medtech solution for preventing pressure ulcers
A new suturing choice for abdominal wall closure
Converting waste flows into valuable raw materials
Innovative systemic anti-inflammatory treatments
Safer medical needles for prostate biopsy
